Pharmacists Inside the Intelligent Health Ecosystem | Pharmacy Podcast Nation

A new report penned by Pamela Spence, EY’s Global Health Sciences and Wellness Industry, explores how heath care in the future will be transformed by a living, intelligent ecosystem that enables care delivery anytime and anywhere, and how pharmacists can utilize AI technologies to make health care even more human. According to EY, there is no single new technology that holds the key to the future of health care. Rather, as technologies such as sensors, cloud computing, AR/VR and 5G continue to evolve and converge with more advanced technologies, like quantum computing and the metaverse, they are enabling the creation of a growing internet of medical things (IoMT), which will extend itself everywhere – beginning with sensors in and on our bodies, to our homes and working environments, and beyond, to smart specialist care facilities. The result: unprecedented growth (36% CAGR over the next three years) in quantity and quality of health data available. Data – particularly the disparate, often unstructured data generated from our daily lives, which is often relevant to health outcomes – requires new analytical tools to turn it from raw information into actionable insights. EY identified two key areas for pharmacists to focus in order to create value in this intelligent health ecosystem of the future: · Personalized insights through artificial intelligence – AI offers a means to connect, combine and interrogate unstructured data differently and unlock actionable insights. With the power of AI, pharmas can begin to link the huge volumes of data generated and the vast array of technological tools being developed into a comprehensive, integrated smart health system. This data-driven smart system enables the breakdown of silos between care settings and optimizes decision-making across the patient journey. · User experience defines the value – The explosion in data and technological innovation offers pharmas a way to reinvent care as a patient-centered, personalized health experience. To succeed in this reinvented world companies will need to consider not only traditional clinical metrics, but also the non-clinical measures which capture the subjective reality of the patient’s own experience. Use of these measures to generate actionable insights via AI will be the pivot for the move from data to value and thus, for BioPharma companies to gain fair reimbursement for innovation and new products. Learn more about your ad choices. Visit megaphone.fm/adchoices